Lokesh Sikaria - Net Worth and Insider Trading

Lokesh Sikaria Net Worth

The estimated net worth of Lokesh Sikaria is at least $247 dollars as of 2024-05-30. Lokesh Sikaria is the 10% Owner of Enveric Biosciences Inc and owns about 330 shares of Enveric Biosciences Inc (ENVB) stock worth over $247. Details can be seen in Lokesh Sikaria's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Lokesh Sikaria has not made any transactions after 2018-11-16 and currently still holds the listed stock(s).

Transaction Summary of Lokesh Sikaria

To

Lokesh Sikaria Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Lokesh Sikaria owns 1 companies in total, including Enveric Biosciences Inc (ENVB) .

Click here to see the complete history of Lokesh Sikaria’s form 4 insider trades.

Insider Ownership Summary of Lokesh Sikaria

Ticker Comapny Transaction Date Type of Owner
ENVB Enveric Biosciences Inc 2018-11-16 10 percent owner

Lokesh Sikaria Latest Holdings Summary

Lokesh Sikaria currently owns a total of 1 stock. Lokesh Sikaria owns 330 shares of Enveric Biosciences Inc (ENVB) as of November 16, 2018, with a value of $247.

Latest Holdings of Lokesh Sikaria

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ENVB Enveric Biosciences Inc 2018-11-16 330 0.75 247

Holding Weightings of Lokesh Sikaria


Lokesh Sikaria Form 4 Trading Tracker

According to the SEC Form 4 filings, Lokesh Sikaria has made a total of 0 transactions in Enveric Biosciences Inc (ENVB) over the past 5 years. The most-recent trade in Enveric Biosciences Inc is the sale of 20 shares on November 16, 2018, which brought Lokesh Sikaria around $30,000.

Insider Trading History of Lokesh Sikaria

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Lokesh Sikaria Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Lokesh Sikaria Ownership Network

Ownership Network List of Lokesh Sikaria

No Data

Ownership Network Relation of Lokesh Sikaria


Lokesh Sikaria Owned Company Details

What does Enveric Biosciences Inc do?

Who are the key executives at Enveric Biosciences Inc?

Lokesh Sikaria is the 10 percent owner of Enveric Biosciences Inc. Other key executives at Enveric Biosciences Inc include Chief Financial Officer Kevin Michael Coveney , Chief Financial Officer Robert Iv Dickey , and Chief Scientific Officer Peter J. Facchini .

Enveric Biosciences Inc (ENVB) Insider Trades Summary

Over the past 18 months, Lokesh Sikaria made no insider transaction in Enveric Biosciences Inc (ENVB). Other recent insider transactions involving Enveric Biosciences Inc (ENVB) include a net purchase of 1,000 shares made by Frank Pasqualone ,

In summary, during the past 3 months, insiders sold 0 shares of Enveric Biosciences Inc (ENVB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Enveric Biosciences Inc (ENVB) were sold and 1,000 shares were bought by its insiders, resulting in a net purchase of 1,000 shares.

Enveric Biosciences Inc (ENVB)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Enveric Biosciences Inc Insider Transactions

No Available Data

Lokesh Sikaria Mailing Address

Above is the net worth, insider trading, and ownership report for Lokesh Sikaria. You might contact Lokesh Sikaria via mailing address: 1659 Manasco Circle, Folsom Ca 95630.

Discussions on Lokesh Sikaria

No discussions yet.